Binosto

Active Ingredient(s): Alendronate Sodium
FDA Approved: * March 12, 2012
Pharm Company: * EFFRX PHARM. SA
Category: Osteoporosis

Alendronic acid, sold under the brand name Fosamax among others, is a bisphosphonate medication used to treat osteoporosis and Paget's disease of bone.[2] It is taken by mouth.[2] Use is often recommended together with vitamin D, calcium supplementation, and lifestyle changes.[2] Common side effects (1 to 10% of patients) include constipation, abdominal pain, nausea, and acid reflux.[2] Use is not recommended during pregnancy or ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Binosto 0.583 mg/ml Oral Solution
NDC: 0178-0101
Labeler:
Mission Pharmacal Company
Binosto 70 mg Oral Tablet, Effervescent
NDC: 17139-400
Labeler:
Ascend Therapeutics

Related Brands

Drugs with the same active ingredients